Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

BACKGROUND: The neutrophil to lymphocyte ratio (NLR) is known to be prognostic for patients with advanced cancers treated with immune checkpoint inhibitors (ICI), but has generally been evaluated as a single threshold value at baseline. We evaluated NLR at baseline and within first month during trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer Res Clin Oncol
Main Authors: Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article – Clinical Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6751277/
https://ncbi.nlm.nih.gov/pubmed/31367835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-02982-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados